Ear nerve stimulation for chronic heart failure
Part of Heart & circulation clinical trials.
This trial tests a non-invasive device that sends gentle electrical pulses to a nerve in your ear (vagus nerve) to see if it improves heart function in people with chronic heart failure. If you have heart failure with a reduced pumping ability, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older and able to make your own medical decisions.
- You must have chronic heart failure with a reduced pumping function (ejection fraction below 50%).
- You must not have had a heart attack or unstable heart condition in the past 3 months.
- You must not have certain heart rhythm problems, such as episodes of fainting or a very slow heartbeat.
- You must not have certain neurological or psychiatric conditions, or be taking certain medications that affect the nervous system.
- You must not have severe kidney, lung, or liver disease, an active cancer, or an untreated thyroid disorder.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a gentle ear stimulation device that may affect heart rate and blood pressure. It aims to see if this stimulation has beneficial effects for healthy people.
This study tests a small device that stimulates a nerve in your ear (not invasive, no needles) for different lengths of time to see how it affects your body. It is for healthy adults and does not involve any drug or surgery.
This trial tests if a gentle nerve stimulation device placed on the ear can help reduce future heart problems after a recent heart attack. It's a non-invasive treatment that may improve recovery.
This study tests a gentle electrical stimulation on the ear to see if it can help people with heart failure feel better while they are in the hospital. It might help reduce symptoms and improve heart function.
This trial tests if a gentle electrical stimulation on the ear (taVNS) can help people with chronic kidney disease (CKD) by improving kidney function or reducing symptoms. It is a non-invasive, device-based treatment given at NYU Langone Health.
This trial tests if a gentle, non-invasive ear stimulation device can help relieve depression in people who have had a heart attack and a stent placed. It aims to offer a drug-free option for those who choose not to take antidepressants or see a therapist.
Hear when a new Heart failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.